Cancer Research Grants
Federal funding for cancer research, clinical trials, and oncology programs from NIH, NCI, and DOD. Covering basic research, translational science, and prevention studies.
Discover and fund active federal grants targeting cancer biology, treatment, screening, and prevention.
Active Opportunities (91)
This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increas...
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The ove...
The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Of...
Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Re...
The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to in...
The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum...
The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to add...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support ...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects...
The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum ...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identif...
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated mid-phase clinical trials o...
This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research i...
The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the developm...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate the adoptio...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) gran...
This Notice of Funding Opportunity (NOFO) encourages applications for research in cancer control and population sciences...
This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) ...
The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the...
Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support ...
Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement e...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support ...
This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basi...
The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the...
Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" ...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to t...
This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseas...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support extramural res...
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to e...
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to e...
The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant suppor...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to t...
TheEngineering of Biomedical Systemsprogram is part of the Engineering Biology and Health cluster, which also includes: ...
The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to in...
TheBiophotonicsprogram is part of the Engineering Biology and Health cluster, which also includes: 1) theBiosensingprogr...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications to support t...
This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basi...
Through this Notice of Funding Opportunity (NOFO) is to accelerate the pace of translation of NCI-supported methods/assa...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation ...
This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support N...
The National Cancer Institute's (NCI) Metastasis Research Network (MetNet) is a collection of U54 Research Centers that ...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating In...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating In...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages grant applications to ...
This Notice of Funding Opportunity (NOFO) solicits applications for the continued development and sustainment of high va...
This Notice of Funding Opportunity (NOFO) invites applications for advanced development and enhancement of emerging info...
This Notice of Funding Opportunity (NOFO) solicits applications for the development of enabling informatics technologies...
This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncolo...
This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncolo...
This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncolo...
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Devel...
Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) supports new i...
Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Translational Research Partnership Award...
Summary: Initially created in FY09, the OCRP Ovarian Cancer Academy (OCA) is a unique, interactive virtual academy provi...
Summary: Supports the addition of independent, early career investigators (Scholars) who are no more than seven years fr...
Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career...
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promisi...
Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Idea Development Award supports the deve...
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) supports t...
Summary: The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-im...
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Idea Development Award (IDA) supports conceptua...
Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Physician Research Award (PRA) Supports a m...
Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Early Investigator Research Award (EIRA) su...
ATTENTION: This announcement will be revised regularly to incorporate country specific narratives (Attachment 1 of the a...
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports adv...
Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a...
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Award...
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Era of Hope Scholar Award supports individual...
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Idea Award (IA) supports innovative, ...
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relativel...
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports re...
Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Focused Pilot Award supports the explora...
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promisi...
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promisi...
Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approac...
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Awar...
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Team Science Award supports a broad range of hypoth...
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Impact Award supports mature research...
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award â Rare Melanomas, supports ...
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Idea Award supports innovative, exploratory, high-r...
Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Data Science Award (DSA) supports research ...
Federal cancer research funding is anchored by the National Cancer Institute (NCI), which awards approximately $6.4 billion annually across its portfolio of basic, translational, clinical, and community-level research programs. The NCI R01 mechanism funds individual investigator-initiated projects at academic institutions and research hospitals, while P01 Program Project Grants support multi-investigator teams tackling complex cancer problems from multiple angles. For research-enabled nonprofits and community organizations, NCI's cancer control and prevention portfolio provides a distinct pathway: community health education, screening outreach, and patient navigation programs receive dedicated funding separate from laboratory research. The Department of Defense Congressionally Directed Medical Research Programs (CDMRP) adds a complementary funding layer with substantial annual appropriations for specific cancers including breast, prostate, lung, and ovarian disease. Eligible applicants span universities, NCI-designated Cancer Centers, independent research institutes, patient advocacy organizations, and community health programs — each with distinct grant mechanisms calibrated to organizational capacity.
Frequently Asked Questions
Explore all federal grant topics or return to the full intelligence feed.